位置:首页 > 蛋白库 > NUD10_HUMAN
NUD10_HUMAN
ID   NUD10_HUMAN             Reviewed;         164 AA.
AC   Q8NFP7; A8K7D7; D3DX69; Q86VK1; Q86VR0;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 160.
DE   RecName: Full=Diphosphoinositol polyphosphate phosphohydrolase 3-alpha {ECO:0000303|PubMed:12105228};
DE            Short=DIPP-3-alpha;
DE            Short=DIPP3-alpha {ECO:0000303|PubMed:12105228};
DE            Short=hDIPP3alpha {ECO:0000303|PubMed:12105228};
DE            EC=3.6.1.52 {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170};
DE   AltName: Full=Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-alpha;
DE   AltName: Full=Diadenosine hexaphosphate hydrolase (AMP-forming);
DE            EC=3.6.1.60 {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170};
DE   AltName: Full=Nucleoside diphosphate-linked moiety X motif 10;
DE            Short=Nudix motif 10;
DE   AltName: Full=hAps2;
GN   Name=NUDT10; Synonyms=APS2, DIPP3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RX   PubMed=12105228; DOI=10.1074/jbc.m205476200;
RA   Hidaka K., Caffrey J.J., Hua L., Zhang T., Falck J.R., Nickel G.C.,
RA   Carrel L., Barnes L.D., Shears S.B.;
RT   "An adjacent pair of human NUDT genes on chromosome X are preferentially
RT   expressed in testis and encode two new isoforms of diphosphoinositol
RT   polyphosphate phosphohydrolase.";
RL   J. Biol. Chem. 277:32730-32738(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, COFACTOR, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND TISSUE SPECIFICITY.
RX   PubMed=12121577; DOI=10.1186/1471-2091-3-20;
RA   Leslie N.R., McLennan A.G., Safrany S.T.;
RT   "Cloning and characterisation of hAps1 and hAps2, human diadenosine
RT   polyphosphate-metabolising Nudix hydrolases.";
RL   BMC Biochem. 3:20-20(2002).
RN   [7]
RP   CATALYTIC ACTIVITY.
RX   PubMed=12370170; DOI=10.1074/jbc.m209795200;
RA   Fisher D.I., Safrany S.T., Strike P., McLennan A.G., Cartwright J.L.;
RT   "Nudix hydrolases that degrade dinucleoside and diphosphoinositol
RT   polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP)
RT   pyrophosphatase activity that generates the glycolytic activator ribose
RT   1,5-bisphosphate.";
RL   J. Biol. Chem. 277:47313-47317(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 17-144 IN COMPLEX WITH CITRATE.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human diphosphoinositol polyphosphate
RT   phosphohydrolase 3-alpha.";
RL   Submitted (APR-2010) to the PDB data bank.
CC   -!- FUNCTION: Cleaves a beta-phosphate from the diphosphate groups in PP-
CC       InsP5 (diphosphoinositol pentakisphosphate), suggesting that it may
CC       play a role in signal transduction. Also able to catalyze the
CC       hydrolysis of dinucleoside oligophosphates, with Ap6A and Ap5A being
CC       the preferred substrates. The major reaction products are ADP and p4a
CC       from Ap6A and ADP and ATP from Ap5A. Also able to hydrolyze 5-
CC       phosphoribose 1-diphosphate. {ECO:0000269|PubMed:12105228}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=diphospho-myo-inositol polyphosphate + H2O = myo-inositol
CC         polyphosphate + phosphate.; EC=3.6.1.52;
CC         Evidence={ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577,
CC         ECO:0000269|PubMed:12370170};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + P(1),P(6)-bis(5'-adenosyl) hexaphosphate = adenosine 5'-
CC         pentaphosphate + AMP + 2 H(+); Xref=Rhea:RHEA:32047,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:63740,
CC         ChEBI:CHEBI:63813, ChEBI:CHEBI:456215; EC=3.6.1.60;
CC         Evidence={ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577,
CC         ECO:0000269|PubMed:12370170};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + P(1),P(5)-bis(5'-adenosyl) pentaphosphate = adenosine
CC         5'-tetraphosphate + AMP + 2 H(+); Xref=Rhea:RHEA:32051,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58450,
CC         ChEBI:CHEBI:62041, ChEBI:CHEBI:456215; EC=3.6.1.60;
CC         Evidence={ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577,
CC         ECO:0000269|PubMed:12370170};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250, ECO:0000269|PubMed:12121577};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250, ECO:0000269|PubMed:12121577};
CC       Note=Binds 3 Mg(2+) or Mn(2+) ions per subunit. Mn(2+) may be the true
CC       cofactor in vivo. {ECO:0000250, ECO:0000269|PubMed:12121577};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.088 uM for PP-InsP5 {ECO:0000269|PubMed:12105228,
CC         ECO:0000269|PubMed:12121577};
CC         KM=19 uM for Ap6A {ECO:0000269|PubMed:12105228,
CC         ECO:0000269|PubMed:12121577};
CC         KM=50 uM for Ap5A {ECO:0000269|PubMed:12105228,
CC         ECO:0000269|PubMed:12121577};
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:12105228,
CC         ECO:0000269|PubMed:12121577};
CC   -!- INTERACTION:
CC       Q8NFP7; O75031: HSF2BP; NbExp=3; IntAct=EBI-726826, EBI-7116203;
CC       Q8NFP7; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-726826, EBI-742948;
CC       Q8NFP7; Q9NR12: PDLIM7; NbExp=3; IntAct=EBI-726826, EBI-350517;
CC       Q8NFP7; Q04864-2: REL; NbExp=3; IntAct=EBI-726826, EBI-10829018;
CC       Q8NFP7; O75971: SNAPC5; NbExp=3; IntAct=EBI-726826, EBI-749483;
CC       Q8NFP7; P15884: TCF4; NbExp=3; IntAct=EBI-726826, EBI-533224;
CC       Q8NFP7; Q9BZR9: TRIM8; NbExp=3; IntAct=EBI-726826, EBI-2340370;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:12121577}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in testis and, at lower level in
CC       brain. According to PubMed:12121577, it is widely expressed.
CC       {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577}.
CC   -!- SIMILARITY: Belongs to the Nudix hydrolase family. DIPP subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF469196; AAM64113.1; -; mRNA.
DR   EMBL; AK291952; BAF84641.1; -; mRNA.
DR   EMBL; AL158055; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471180; EAW89910.1; -; Genomic_DNA.
DR   EMBL; CH471180; EAW89911.1; -; Genomic_DNA.
DR   EMBL; BC049383; AAH49383.1; -; mRNA.
DR   EMBL; BC050700; AAH50700.1; -; mRNA.
DR   CCDS; CCDS35278.1; -.
DR   RefSeq; NP_001291892.1; NM_001304963.1.
DR   RefSeq; NP_694853.1; NM_153183.3.
DR   PDB; 3MCF; X-ray; 2.00 A; A/B=17-144.
DR   PDBsum; 3MCF; -.
DR   AlphaFoldDB; Q8NFP7; -.
DR   SMR; Q8NFP7; -.
DR   BioGRID; 128079; 18.
DR   IntAct; Q8NFP7; 9.
DR   STRING; 9606.ENSP00000365174; -.
DR   ChEMBL; CHEMBL4295904; -.
DR   iPTMnet; Q8NFP7; -.
DR   PhosphoSitePlus; Q8NFP7; -.
DR   BioMuta; NUDT10; -.
DR   DMDM; 68565913; -.
DR   EPD; Q8NFP7; -.
DR   jPOST; Q8NFP7; -.
DR   MassIVE; Q8NFP7; -.
DR   MaxQB; Q8NFP7; -.
DR   PaxDb; Q8NFP7; -.
DR   PeptideAtlas; Q8NFP7; -.
DR   PRIDE; Q8NFP7; -.
DR   ProteomicsDB; 73332; -.
DR   Antibodypedia; 26316; 199 antibodies from 22 providers.
DR   DNASU; 170685; -.
DR   Ensembl; ENST00000356450.3; ENSP00000348831.2; ENSG00000122824.11.
DR   Ensembl; ENST00000376006.7; ENSP00000365174.3; ENSG00000122824.11.
DR   GeneID; 170685; -.
DR   KEGG; hsa:170685; -.
DR   MANE-Select; ENST00000356450.3; ENSP00000348831.2; NM_001304963.2; NP_001291892.1.
DR   UCSC; uc004dph.3; human.
DR   CTD; 170685; -.
DR   DisGeNET; 170685; -.
DR   GeneCards; NUDT10; -.
DR   HGNC; HGNC:17621; NUDT10.
DR   HPA; ENSG00000122824; Tissue enhanced (testis).
DR   MIM; 300527; gene.
DR   neXtProt; NX_Q8NFP7; -.
DR   OpenTargets; ENSG00000122824; -.
DR   PharmGKB; PA31831; -.
DR   VEuPathDB; HostDB:ENSG00000122824; -.
DR   eggNOG; KOG2839; Eukaryota.
DR   GeneTree; ENSGT01040000240679; -.
DR   HOGENOM; CLU_037162_1_0_1; -.
DR   InParanoid; Q8NFP7; -.
DR   OMA; VEKNECA; -.
DR   OrthoDB; 1324716at2759; -.
DR   PhylomeDB; Q8NFP7; -.
DR   TreeFam; TF106349; -.
DR   BioCyc; MetaCyc:HS04604-MON; -.
DR   BRENDA; 3.6.1.60; 2681.
DR   PathwayCommons; Q8NFP7; -.
DR   Reactome; R-HSA-1855167; Synthesis of pyrophosphates in the cytosol.
DR   SignaLink; Q8NFP7; -.
DR   BioGRID-ORCS; 170685; 17 hits in 611 CRISPR screens.
DR   ChiTaRS; NUDT10; human.
DR   EvolutionaryTrace; Q8NFP7; -.
DR   GenomeRNAi; 170685; -.
DR   Pharos; Q8NFP7; Tbio.
DR   PRO; PR:Q8NFP7; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q8NFP7; protein.
DR   Bgee; ENSG00000122824; Expressed in cortical plate and 121 other tissues.
DR   Genevisible; Q8NFP7; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0034431; F:bis(5'-adenosyl)-hexaphosphatase activity; IBA:GO_Central.
DR   GO; GO:0034432; F:bis(5'-adenosyl)-pentaphosphatase activity; IBA:GO_Central.
DR   GO; GO:0008486; F:diphosphoinositol-polyphosphate diphosphatase activity; ISS:UniProtKB.
DR   GO; GO:0000298; F:endopolyphosphatase activity; IBA:GO_Central.
DR   GO; GO:0052842; F:inositol diphosphate pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052840; F:inositol diphosphate tetrakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050072; F:m7G(5')pppN diphosphatase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:1901911; P:adenosine 5'-(hexahydrogen pentaphosphate) catabolic process; IBA:GO_Central.
DR   GO; GO:1901909; P:diadenosine hexaphosphate catabolic process; IBA:GO_Central.
DR   GO; GO:1901907; P:diadenosine pentaphosphate catabolic process; IBA:GO_Central.
DR   GO; GO:0071543; P:diphosphoinositol polyphosphate metabolic process; IBA:GO_Central.
DR   InterPro; IPR015797; NUDIX_hydrolase-like_dom_sf.
DR   InterPro; IPR020084; NUDIX_hydrolase_CS.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   Pfam; PF00293; NUDIX; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
DR   PROSITE; PS00893; NUDIX_BOX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Hydrolase; Magnesium; Manganese; Metal-binding;
KW   Reference proteome.
FT   CHAIN           1..164
FT                   /note="Diphosphoinositol polyphosphate phosphohydrolase 3-
FT                   alpha"
FT                   /id="PRO_0000057062"
FT   DOMAIN          17..144
FT                   /note="Nudix hydrolase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00794"
FT   REGION          144..164
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           50..71
FT                   /note="Nudix box"
FT   COMPBIAS        147..164
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        68
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         9
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   BINDING         17..19
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   BINDING         38..40
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   BINDING         49
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   BINDING         65
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   BINDING         65
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   BINDING         69
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   BINDING         89..91
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   BINDING         115
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   BINDING         133
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O95989"
FT   CONFLICT        90
FT                   /note="K -> E (in Ref. 5; AAH50700)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        135
FT                   /note="V -> M (in Ref. 5; AAH49383)"
FT                   /evidence="ECO:0000305"
FT   STRAND          18..27
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   STRAND          39..41
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   STRAND          44..46
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   STRAND          49..51
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   HELIX           58..70
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   STRAND          72..83
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   STRAND          92..103
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   HELIX           108..113
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   STRAND          117..121
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   HELIX           122..130
FT                   /evidence="ECO:0007829|PDB:3MCF"
FT   HELIX           134..144
FT                   /evidence="ECO:0007829|PDB:3MCF"
SQ   SEQUENCE   164 AA;  18500 MW;  589F342E02B285A7 CRC64;
     MKCKPNQTRT YDPEGFKKRA ACLCFRSERE DEVLLVSSSR YPDRWIVPGG GMEPEEEPGG
     AAVREVYEEA GVKGKLGRLL GVFEQNQDPK HRTYVYVLTV TELLEDWEDS VSIGRKREWF
     KVEDAIKVLQ CHKPVHAEYL EKLKLGGSPT NGNSMAPSSP DSDP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025